ARCHIVES

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

DCE Concepts Statements

March 11, 1988